CHLD
CHANGE OF OWNER RECEIVED FROM IB
07/30/2026
Back to search
Official data from USPTO
CALMANDRIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
CALMANDRIN
ST13
US500000079353339Class
1, 3
Filing
79353339
Registration
7178582
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
07/31/2026
Classification
Registered
Trademark type
Word
Nice classes
1, 3
Filing date
08/26/2022
Registration date
10/03/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/03/2023
Last transaction
07/31/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
CH
Examiner
KEAN, AMY C
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Solabia Biochemistry AG
Mibelle AG
Migros-Genossenschafts-Bund
Representatives
Migros-Genossenschafts-Bund
Technical classification
Nice Classes
Class 1Class 3
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical and biological active agents for manufacture of cosmetic preparations as well as skin and beauty care products
Class 3
Non-medicated soaps; perfumesessential oils; non-medicated toiletry preparations and cosmetic products; non-medicated hair lotions; non-medicated dentifrices
Publications
History of USPTO decisions and trademark events.
16 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/04/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/08/2025
CHLD
CHANGE OF OWNER RECEIVED FROM IB
06/27/2025
GPNX
NOTIFICATION PROCESSED BY IB
11/26/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/03/2023
FIMP
FINAL DISPOSITION PROCESSED
11/03/2023
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
11/02/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
10/03/2023
PUBO
PUBLISHED FOR OPPOSITION
07/18/2023
NPUB
NOTICE OF PUBLICATION
06/28/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/15/2023
DOCK
ASSIGNED TO EXAMINER
06/13/2023
MAFR
APPLICATION FILING RECEIPT MAILED
10/25/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/21/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/20/2022
Continuous trademark protection
Get notified about every new filing that threatens CALMANDRIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.